Chiesi Group

Casa
Italia
Parma
Chiesi Group

International pharmaceutical Group certified B Corp.

08/03/2026

Equity means more than metrics: it’s a journey to foster access, visibility, and meaningful support for every talent.
At Chiesi, we keep empowering women at every stage of their career by providing equal opportunities and fair pay, ensuring balanced gender representation in leadership roles, and supporting their growth through dedicated mentoring, coaching, and networking programs.

This , we celebrate progress and reaffirm our commitment to creating an environment where women can thrive.

28/02/2026

Listening connects us, to each other, to our communities, and to people living with rare diseases around the world.

This , through our immersive “Sound of Rare” experience, colleagues across the globe took a moment to truly listen to the voices and stories of the rare disease community.

Afterward, each person wrote down one key learning. Every note was then linked together to form a paper chain, a visual reminder of how listening brings us closer and strengthens our connection as a global community.
Learn more at: https://www.rarediseaseday.org/

Chiesi Global Rare Diseases

12/02/2026

Tackling climate-related respiratory disease means tackling inequality.

The most vulnerable communities breathe dirtier air, face longer allergy seasons, and often miss early diagnosis. Non-physiological factors—income, housing, occupation, education, access to care and local air quality—have the greatest influence on lung health.

While pollution remains Europe’s biggest environmental health challenge, we have the power to change that.
By acting now, Europe can lead the way with cleaner cities, stronger health systems, and safer workplaces—helping to prevent asthma and COPD (Chronic Obstructive Pulmonary Disease) and protect those most at risk. Together, we can turn this challenge into progress.

Learn more at: https://ow.ly/OBYf50Yebt7

11/02/2026

From discovery to regulatory affairs, our colleagues advance science every day to improve people’s lives.

On the International Day of Women and Girls in Science, we celebrate the passion, ideas and vision of the women in our R&D community and share what inspires them to keep moving science forward.

Meet the people behind the progress!👩‍🔬

22/01/2026

È stata rinnovata la certificazione UNI/PdR 125 sulla parità di genere per Chiesi Farmaceutici S.p.A. e Chiesi Italia, un riconoscimento che premia il nostro impegno costante nel garantire equità e inclusione in ogni ambito della vita aziendale.

La parità di genere è parte integrante della nostra cultura: garantiamo equità retributiva, trasparenza e politiche di welfare che supportano ogni fase della vita, inclusi i congedi di genitorialità retribuiti al 100% per tutti i genitori.

Questo risultato rappresenta un ulteriore passo avanti verso un ambiente di lavoro in cui ciascuno può esprimere pienamente il proprio potenziale.

20/01/2026

Understanding patients' needs is the starting point for real innovation in healthcare.

At Chiesi, the Patient Journey framework is central to our patient-driven approach. It helps us map every step, from the awareness of health conditions and risk factors to diagnosis, treatment, and follow-up care.

By capturing not only the patient’s experience but also the perspectives of all stakeholders involved, it enables us to co-create integrated, sustainable solutions that go beyond the product.

🎥 Watch Noemi's video to learn how we turn insights into impact.

15/01/2026

We’re proud to share that Chiesi has been recertified as a !
This global recognition highlights our ongoing dedication to fostering a workplace where everyone can grow, succeed, and create a meaningful impact.

In 2026, we achieved the certification in Italy, Germany, France, Spain, UK, Greece, Poland, United States and China!
Together we are shaping a workplace committed to excellence and innovation, where everyone can access opportunities and contribute to have an impact.

👏 A huge congratulations to our colleagues at Chiesi Italia, Chiesi France, Chiesi Deutschland, Chiesi Hellas, Chiesi España & Portugal, Chiesi UK, Chiesi Polska, Chiesi USA, Chiesi China and all those who made this achievement possible!

08/01/2026

Not every journey into the world goes exactly as planned.

For over 30 years, we’ve been dedicated to improving neonatal care: setting new standards, developing innovative solutions, and being there for families when it matters most.

When a baby is born before 37 weeks, it’s considered premature — a circumstance that touches 1 in 10 newborns and countless families worldwide.
Learn more about prematurity 👉

23/12/2025

90 years of countless stories and one shared purpose.

From a small lab in Parma to a global company, our journey has been driven by generations of passionate people.
Almost 2,000 colleagues came together in Parma to celebrate a legacy of progress, purpose, and innovation.

Wishing you Happy Holidays and a wonderful start to the new year. Here’s to shaping the next chapter together!

22/12/2025

Innovation thrives when generations come together!

Through our JOY program – Join the future of Chiesi strategy – we connect early-career professionals and executives in a meaningful, cross-generational exchange, bringing fresh perspectives, diverse mindsets, and the courage to challenge ideas, decisions, and assumptions with authenticity and mutual respect.

At Chiesi, we see generational diversity as an opportunity to grow stronger together.

11/12/2025

Every child deserves an equal start in life.

For preterm newborns and their families, access to care can mean the difference between fragility and opportunity.

At Chiesi, our Health Equity strategy is designed to remove barriers and reduce health disparities, ensuring timely, quality care for all, everywhere. Together, we can give every preterm newborn the same chance to grow and live a healthy life.

09/12/2025

Proud to Be a Re-Certified B Corp!

Chiesi Group has achieved B Corp certification for the third time, a milestone that demonstrates measurable progress in our social and environmental impact.

From our first certification in 2019 to now our third in 2025, this achievement is a testament to our commitment to sustainability and using business as a force for good.
Learn more about our achievement and stay tuned to discover what this milestone truly means for us:
https://www.chiesi.com/b-corp-journey/

B Lab

Indirizzo

Via Palermo 26A
Parma
43122

Sito Web

http://www.chiesi.com/

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando Chiesi Group pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.

Contatta Lo Studio

Invia un messaggio a Chiesi Group:

Vuoi che la tua studio sia il Clinica più quotato a Parma?

Digitare

Azienda farmaceutica

Who we are

Chiesi is an international company originated in Parma, with 85 years of experience and a strong focus on research, development, production and commercialization of innovative therapeutic solutions in the Respiratory, Neonatology, Rare Diseases and Special Care Therapeutic Areas. We are value-oriented, passionate, supportive and a global family with nearly 6.000 employees and 29 affiliates who have a real impact on people's lives in 90 countries around the world. With a turnover of nearly €2 billion sales, we are among the top 50 pharmaceutical companies in the world. Chiesi is the largest global pharmaceutical Group to be awarded B Corp Certification, a recognition of high social and environmental standards. We want to use business as a force for good and create a positive impact on people, environment and community.